Illumina Accelerator graduate, Resilient Biotics, Inc., shares its experiences on launching a breakthrough genomics startup. Hear from Chris Belnap, PhD, CEO of Resilient Biotics about his journeys at Illumina Accelerator. From capital, to sequencing expertise, to business coaching, and world-class facilities in San Francisco Bay Area, Illumina Accelerator helps drive value for your genomics startup and unlock the power of the genome to improve human health and beyond.
Learn more about our featured startups:
Subscribe to the Illumina video channel
Accelerator Illumina Accelerator is the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. It provides select startups with seed investment, business guidance, access to Illumina’s sequencing systems and reagents, and fully operational lab space in the San Francisco Bay Area during each six-month funding cycle.
For more information, visit http://www.illumina.com/accelerator
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015.
Subscribe to the Illumina video channel